MLchartDataset catalogue

17-AAG

Term · Oncology and biomedicine · MLC-T-ONC-000014

A substance being studied in the treatment of cancer. It is made from an antibiotic called geldanamycin. 17-AAG helps cause the breakdown of certain proteins in the cell, and may kill cancer cells. It is a type of antineoplastic antibiotic and a type of HSP90 inhibitor. Also called 17-N-allylamino-17-demethoxygeldanamycin and tanespimycin.

Table 1. Record
IdentifierMLC-T-ONC-000014
FieldOncology and biomedicine
Expansions17-N-allylamino-17-demethoxygeldanamycin; tanespimycin
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-000014",
  "term": "17-AAG",
  "field": "Oncology and biomedicine",
  "definition": "A substance being studied in the treatment of cancer. It is made from an antibiotic called geldanamycin. 17-AAG helps cause the breakdown of certain proteins in the cell, and may kill cancer cells. It is a type of antineoplastic antibiotic and a type of HSP90 inhibitor. Also called 17-N-allylamino-17-demethoxygeldanamycin and tanespimycin.",
  "expansions": [
    "17-N-allylamino-17-demethoxygeldanamycin",
    "tanespimycin"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/17-aag/"
}

Record 22 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.